Joel Greenblatt Alnylam Pharmaceuticals, Inc. Transaction History

Gotham Asset Management, LLC

$16.1 Billion
Q2 2025

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 17,787 shares of ALNY stock, worth $7.86 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

17,787

Previous 14,517 22.53%

Holding current value

$7.86 Million

Previous $3.92 Million 48.0%

% of portfolio

0.04%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$224.32 - $326.09 $733,526 - $1.07 Million	3,270 Added 22.53%	17,787 $5.8 Million
Q1 2025 May 15, 2025	BUY	$233.07 - $290.7 $837,420 - $1.04 Million	3,593 Added 32.89%	14,517 $3.92 Million
Q4 2024 Feb 14, 2025	SELL	$232.27 - $300.43 $1.54 Million - $2 Million	-6,651 Reduced 37.84%	10,924 $2.57 Million
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $1.01 Million - $1.25 Million	4,338 Added 32.77%	17,575 $4.83 Million
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $1.6 Million - $2.76 Million	11,190 Added 546.65%	13,237 $3.22 Million
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $1.28 Million - $1.74 Million	-8,762 Reduced 81.06%	2,047 $305,000
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $1.17 Million - $1.52 Million	7,727 Added 250.71%	10,809 $2.07 Million
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $132,346 - $164,028	-775 Reduced 20.09%	3,082 $545,000
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $232,927 - $266,970	-1,259 Reduced 24.61%	3,857 $732,000
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $316,001 - $407,466	1,730 Added 51.09%	5,116 $1.02 Million
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $556 - $723	3 Added 0.09%	3,386 $804,000
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $38,375 - $64,264	277 Added 8.92%	3,383 $677,000
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $217,719 - $306,076	1,808 Added 139.29%	3,106 $453,000
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $165,079 - $225,735	1,298 New	1,298 $212,000
Q2 2020 Aug 13, 2020	SELL	$104.21 - $156.44 $465,193 - $698,348	-4,464 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $143,777 - $206,880	1,544 Added 52.88%	4,464 $486,000
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $217,569 - $362,751	2,920 New	2,920 $336,000
Q4 2017 Feb 14, 2018	SELL	$114.49 - $139.98 $286,110 - $349,810	-2,499 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $181,252 - $295,556	2,499	2,499 $294,000

Others Institutions Holding ALNY

# of Institutions

840

Shares Held

118M

Call Options Held

608K

Put Options Held

678K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $54.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account